These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38893193)

  • 21. Simulated multileaf collimator tracking for stereotactic liver radiotherapy guided by kilovoltage intrafraction monitoring: Dosimetric gain and target overdose trends.
    Poulsen PR; Murtaza G; Worm ES; Ravkilde T; O'Brien R; Grau C; Høyer M; Keall P
    Radiother Oncol; 2020 Mar; 144():93-100. PubMed ID: 31786423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
    Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
    Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosimetric and deformation effects of image-guided interventions during stereotactic body radiation therapy of the prostate using an endorectal balloon.
    Jones BL; Gan G; Diot Q; Kavanagh B; Timmerman RD; Miften M
    Med Phys; 2012 Jun; 39(6):3080-8. PubMed ID: 22755693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors.
    Padgett KR; Simpson GN; Llorente R; Samuels MA; Dogan N
    Cureus; 2018 Apr; 10(4):e2423. PubMed ID: 29872603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interfraction Anatomical Variability Can Lead to Significantly Increased Rectal Dose for Patients Undergoing Stereotactic Body Radiotherapy for Prostate Cancer.
    Wahl M; Descovich M; Shugard E; Pinnaduwage D; Sudhyadhom A; Chang A; Roach M; Gottschalk A; Chen J
    Technol Cancer Res Treat; 2017 Apr; 16(2):178-187. PubMed ID: 27199276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interfractional Geometric Variations and Dosimetric Benefits of Stereotactic MRI Guided Online Adaptive Radiotherapy (SMART) of Prostate Bed after Radical Prostatectomy: Post-Hoc Analysis of a Phase II Trial.
    Cao M; Gao Y; Yoon SM; Yang Y; Sheng K; Ballas LK; Basehart V; Sachdeva A; Felix C; Low DA; Steinberg ML; Kishan AU
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simulating an intra-fraction adaptive workflow to enable PTV margin reduction in MRIgART volumetric modulated arc therapy for prostate SBRT.
    Snyder J; Smith B; Aubin JS; Shepard A; Hyer D
    Front Oncol; 2023; 13():1325105. PubMed ID: 38260830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer.
    El-Bared N; Portelance L; Spieler BO; Kwon D; Padgett KR; Brown KM; Mellon EA
    Pract Radiat Oncol; 2019 Jan; 9(1):e46-e54. PubMed ID: 30149192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison between high dose rate brachytherapy and stereotactic body radiotherapy boost after elective pelvic irradiation for high and very high-risk prostate cancer.
    Novikov SN; Novikov RV; Merezhko YO; Gotovchikova MY; Ilin ND; Melnik YS; Kanaev SV
    Radiat Oncol J; 2022 Sep; 40(3):200-207. PubMed ID: 36200309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: A post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiotherapy.
    Ma TM; Neylon J; Casado M; Sharma S; Sheng K; Low D; Yang Y; Steinberg ML; Lamb J; Cao M; Kishan AU
    Radiother Oncol; 2022 Feb; 167():203-210. PubMed ID: 34979212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial.
    Ristau J; Hörner-Rieber J; Buchele C; Klüter S; Jäkel C; Baumann L; Andratschke N; Garcia Schüler H; Guckenberger M; Li M; Niyazi M; Belka C; Herfarth K; Debus J; Koerber SA
    Radiat Oncol; 2022 Apr; 17(1):75. PubMed ID: 35428327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetric impact of intrafraction motion under abdominal compression during MR-guided SBRT for (Peri-) pancreatic tumors.
    Grimbergen G; Eijkelenkamp H; Heerkens HD; Raaymakers BW; Intven MPW; Meijer GJ
    Phys Med Biol; 2022 Sep; 67(18):. PubMed ID: 36041431
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of intrafraction motion in pancreatic cancer treatments with MR-guided adaptive radiation therapy.
    Rusu DN; Cunningham JM; Arch JV; Chetty IJ; Parikh PJ; Dolan JL
    Front Oncol; 2023; 13():1298099. PubMed ID: 38162503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What benefit could be derived from on-line adaptive prostate radiotherapy using rectal diameter as a predictor of motion?
    Oates R; Gill S; Foroudi F; Joon ML; Schneider M; Bressel M; Kron T
    J Med Phys; 2015; 40(1):18-23. PubMed ID: 26150683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brachytherapy Versus Stereotactic Body Radiotherapy for Cervical Cancer Boost: A Dosimetric Comparison.
    Dahbi Z; Fadila K; Vinh-Hung V
    Cureus; 2023 Apr; 15(4):e37235. PubMed ID: 37038382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of intrafraction changes in delivered dose of the day for prostate cancer patients treated with stereotactic body radiotherapy via MR-Linac.
    Dang J; Kong V; Li W; Navarro I; Winter JD; Malkov V; Berlin A; Catton C; Padayachee J; Raman S; Warde P; Chung P
    Tech Innov Patient Support Radiat Oncol; 2022 Sep; 23():41-46. PubMed ID: 36105770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR).
    Kim M; Schiff JP; Price A; Laugeman E; Samson PP; Kim H; Badiyan SN; Henke LE
    Radiat Oncol; 2022 Sep; 17(1):157. PubMed ID: 36100866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional imaging guided stereotactic ablative body radiotherapy (SABR) with focal dose escalation and bladder trigone sparing for intermediate and high-risk prostate cancer: study protocol for phase II safo trial.
    Zapatero A; Castro P; Roch M; Carnero PR; Carroceda S; Rosciupchin AES; Hernández SH; Cogorno L; Iturriaga AG; García DB
    Radiat Oncol; 2024 May; 19(1):54. PubMed ID: 38702761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of rectal enema on intrafraction prostate movement during image-guided radiotherapy.
    Choi Y; Kwak DW; Lee HS; Hur WJ; Cho WY; Sung GT; Kim TH; Kim SD; Yun SG
    J Med Imaging Radiat Oncol; 2015 Apr; 59(2):236-42. PubMed ID: 25229723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SU-E-J-214: Target Intrafraction Motion Dosimetric Impact on 5-Fraction Proton Prostate SBRT.
    Su Z; Slopsema R; Flampouri S; Li Z
    Med Phys; 2012 Jun; 39(6Part9):3702. PubMed ID: 28519044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.